France· FR:68156358
PENTOXIFYLLINE EG LP 400 mg, comprimé pelliculé à libération prolongée
A pentoxifylline product containing pentoxifylline, registered in France by EG LABO - LABORATOIRES EUROGENERICS. The same ATC class is registered in 12 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Pentoxifylline is registered in 12 of 19 countries.
Countries holding a registration under ATC C04AD03 (pentoxifylline), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 7 of them publish a price we can compare per daily dose
Pentoxifylline · ATC C04AD03
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- PENTOXIFYLLINE
- Manufacturer
- EG LABO - LABORATOIRES EUROGENERICS
- Country
- France (FR)
- ATC code
- C04AD03
- ATC class
- Pentoxifylline
- Defined daily dose
- 1 g, O
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip133400935879226plaquette(s) thermoformée(s) PVC PVDC aluminium de 30 comprimé(s)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
435 interactions on record for pentoxifylline.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Pentoxifylline · interactions on record
435 records
- 4 severe
- 252 moderate
- 179 info
Most severe, free to view
- CimetidineA02BA01moderate
- PapaverineA03AD01moderate
- Obeticholic acidA05AA04moderate
- MannitolA06AD16moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Pentoxifylline in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandApo-Pentox 400 SRAurovitas Pharma Polska Sp. z o.o.
- United KingdomNeotren MR 400mg tabletsFannin (UK) Ltd
- United StatesPentoxifyllineRising Pharma Holdings, Inc.
- CzechiaAGAPURINZentiva, k.s., Praha
- SpainELORGAN 400 mg COMPRIMIDOS DE LIBERACION PROLONGADANeuraxpharm Spain S.L.U.
- GermanyPentoxifyllin 1 A Pharma1 A Pharma Gmbh
- BelgiumTorental 400 mgPI Pharma
- FinlandArtalAyanda Oy
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Austria · Pentomer Retard, Pentoxi Retard
- Belgium · Torental
- Bulgaria · Агапурин, Агапурин Sr
- Cyprus · Angiopent Retard, Tarοntal
- Czechia · Agapurin, Pentomer Retard
- Germany · Pentoxifyllin 1 A Pharma, Pentoxifyllin Ratiopharm
- Estonia · Pentilin, Vasonit Retard
- Spain · Elorgan, Hemovás
- United Kingdom (Northern Ireland) · Pentoxifylline Neuraxpharm Uk
- Greece · Tarontal
- Croatia · Pentilin, Trental
- Hungary · Chinotal, Pentoxyl
- Italy · Trental
- Lithuania · Agapurin, Pentilin
- Luxembourg · Pentoxifylline Ratiopharm, Torental
- Latvia · Pentilin, Polfilin
- Netherlands · Trental
- Norway · Trental
- Poland · Agapurin, Agapurin Sr
- Portugal · Pentoxifilina Generis, Trental
- Romania · Angiopent Retard, Pentoxi Retard
- Slovenia · Pentilin
- Slovakia · Agapurin, Agapurin Sr
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4aaa56cf-d681-4f1d-a68a-05a6099a62a1 GET /v1/drugs/4aaa56cf-d681-4f1d-a68a-05a6099a62a1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "68156358",
"date_amm": "2002-01-18",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "PENTOXIFYLLINE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "comprimé pelliculé à libération prolongée",
"voies_administration": "orale",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about pentoxifylline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.